ID   UBC12_HUMAN             Reviewed;         183 AA.
AC   P61081; O76069; Q8VC50;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 1.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=NEDD8-conjugating enzyme Ubc12;
DE            EC=6.3.2.-;
DE   AltName: Full=NEDD8 carrier protein;
DE   AltName: Full=NEDD8 protein ligase;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2 M;
GN   Name=UBE2M; Synonyms=UBC12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9694792; DOI=10.1101/gad.12.15.2263;
RA   Osaka F., Kawasaki H., Aida N., Saeki M., Chiba T., Kawashima S.,
RA   Tanaka K., Kato S.;
RT   "A new NEDD8-ligating system for cullin-4A.";
RL   Genes Dev. 12:2263-2268(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=10207026; DOI=10.1074/jbc.274.17.12036;
RA   Gong L., Yeh E.T.H.;
RT   "Identification of the activating and conjugating enzymes of the NEDD8
RT   conjugation pathway.";
RL   J. Biol. Chem. 274:12036-12042(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   MUTAGENESIS OF CYS-111.
RX   PubMed=10828074; DOI=10.1074/jbc.275.22.17008;
RA   Wada H., Yeh E.T.H., Kamitani T.;
RT   "A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8
RT   conjugation in vivo.";
RL   J. Biol. Chem. 275:17008-17015(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   INTERACTION WITH RBX1.
RX   PubMed=19250909; DOI=10.1016/j.molcel.2009.01.011;
RA   Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M.,
RA   Scott D.C., Borg L.A., Neale G., Murray P.J., Roussel M.F.,
RA   Schulman B.A.;
RT   "E2-RING expansion of the NEDD8 cascade confers specificity to cullin
RT   modification.";
RL   Mol. Cell 33:483-495(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-169, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-26 IN COMPLEX WITH UBA3 AND
RP   NAE1, MUTAGENESIS OF MET-1; LEU-4; PHE-5; SER-6; LEU-7; GLN-9; GLN-10;
RP   LYS-11 AND LYS-12, AND FUNCTION.
RX   PubMed=15361859; DOI=10.1038/nsmb826;
RA   Huang D.T., Miller D.W., Mathew R., Cassell R., Holton J.M.,
RA   Roussel M.F., Schulman B.A.;
RT   "A unique E1-E2 interaction required for optimal conjugation of the
RT   ubiquitin-like protein NEDD8.";
RL   Nat. Struct. Mol. Biol. 11:927-935(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-183 IN COMPLEX WITH UBA3
RP   AND NAE1, AND MUTAGENESIS OF LEU-32; GLN-35; LYS-36; ILE-38; ASN-39;
RP   LEU-41; PHE-51; ASP-55 AND LEU-57.
RX   PubMed=15694336; DOI=10.1016/j.molcel.2004.12.020;
RA   Huang D.T., Paydar A., Zhuang M., Waddell M.B., Holton J.M.,
RA   Schulman B.A.;
RT   "Structural basis for recruitment of Ubc12 by an E2 binding domain in
RT   NEDD8's E1.";
RL   Mol. Cell 17:341-350(2005).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 2-15 IN COMPLEX WITH CUL1 AND
RP   DCUN1D1, X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-12 IN COMPLEX WITH
RP   CUL1 AND DCUN1D1, ACETYLATION AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=21940857; DOI=10.1126/science.1209307;
RA   Scott D.C., Monda J.K., Bennett E.J., Harper J.W., Schulman B.A.;
RT   "N-terminal acetylation acts as an avidity enhancer within an
RT   interconnected multiprotein complex.";
RL   Science 334:674-678(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (3.28 ANGSTROMS) OF 1-12 IN COMPLEX WITH
RP   DCUN1D2, AND ACETYLATION AT MET-1.
RX   PubMed=23201271; DOI=10.1016/j.str.2012.10.013;
RA   Monda J.K., Scott D.C., Miller D.J., Lydeard J., King D., Harper J.W.,
RA   Bennett E.J., Schulman B.A.;
RT   "Structural conservation of distinctive N-terminal acetylation-
RT   dependent interactions across a family of mammalian NEDD8 ligation
RT   enzymes.";
RL   Structure 21:42-53(2013).
CC   -!- FUNCTION: Accepts the ubiquitin-like protein NEDD8 from the UBA3-
CC       NAE1 E1 complex and catalyzes its covalent attachment to other
CC       proteins. The specific interaction with the E3 ubiquitin ligase
CC       RBX1, but not RBX2, suggests that the RBX1-UBE2M complex
CC       neddylates specific target proteins, such as CUL1, CUL2, CUL3 and
CC       CUL4. Involved in cell proliferation.
CC       {ECO:0000269|PubMed:10207026, ECO:0000269|PubMed:15361859}.
CC   -!- CATALYTIC ACTIVITY: ATP + NEDD8 + protein lysine = AMP +
CC       diphosphate + protein N-NEDD8yllysine.
CC   -!- PATHWAY: Protein modification; protein neddylation.
CC   -!- SUBUNIT: Interacts with UBA3, DCUN1D1 and RBX1.
CC       {ECO:0000269|PubMed:15361859, ECO:0000269|PubMed:15694336,
CC       ECO:0000269|PubMed:19250909, ECO:0000269|PubMed:21940857,
CC       ECO:0000269|PubMed:23201271}.
CC   -!- INTERACTION:
CC       Q13616:CUL1; NbExp=5; IntAct=EBI-1041660, EBI-359390;
CC       Q15843:NEDD8; NbExp=3; IntAct=EBI-1041660, EBI-716247;
CC       P62877:RBX1; NbExp=3; IntAct=EBI-1041660, EBI-398523;
CC       Q8TBC4:UBA3; NbExp=2; IntAct=EBI-1041660, EBI-717567;
CC   -!- DOMAIN: Both the N-terminal docking peptide and the catalytic core
CC       domain must bind the UBA3-NAE1 complex simultaneously for optimal
CC       transfer of NEDD8.
CC   -!- PTM: The acetylation of Met-1 increases affinity for DCUN1D1 by
CC       about 2 orders of magnitude and is crucial for NEDD8 transfer to
CC       cullins. {ECO:0000269|PubMed:21940857,
CC       ECO:0000269|PubMed:23201271}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       UBC12 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB012191; BAA33145.1; -; mRNA.
DR   EMBL; AF075599; AAC26141.1; -; mRNA.
DR   EMBL; BT006754; AAP35400.1; -; mRNA.
DR   EMBL; BC058924; AAH58924.1; -; mRNA.
DR   CCDS; CCDS12987.1; -.
DR   RefSeq; NP_003960.1; NM_003969.3.
DR   UniGene; Hs.406068; -.
DR   PDB; 1TT5; X-ray; 2.60 A; E/F=1-26.
DR   PDB; 1Y8X; X-ray; 2.40 A; A=27-183.
DR   PDB; 2NVU; X-ray; 2.80 A; C=1-178.
DR   PDB; 3TDU; X-ray; 1.50 A; E/F=1-15.
DR   PDB; 3TDZ; X-ray; 2.00 A; E/F=2-12.
DR   PDB; 4GAO; X-ray; 3.28 A; C/E/F/H=1-12.
DR   PDB; 4P5O; X-ray; 3.11 A; G/I=2-183.
DR   PDBsum; 1TT5; -.
DR   PDBsum; 1Y8X; -.
DR   PDBsum; 2NVU; -.
DR   PDBsum; 3TDU; -.
DR   PDBsum; 3TDZ; -.
DR   PDBsum; 4GAO; -.
DR   PDBsum; 4P5O; -.
DR   ProteinModelPortal; P61081; -.
DR   SMR; P61081; -.
DR   BioGrid; 114504; 81.
DR   DIP; DIP-35679N; -.
DR   IntAct; P61081; 17.
DR   MINT; MINT-5002641; -.
DR   STRING; 9606.ENSP00000253023; -.
DR   iPTMnet; P61081; -.
DR   PhosphoSitePlus; P61081; -.
DR   SwissPalm; P61081; -.
DR   BioMuta; UBE2M; -.
DR   DMDM; 46577655; -.
DR   REPRODUCTION-2DPAGE; IPI00022597; -.
DR   UCD-2DPAGE; P61081; -.
DR   EPD; P61081; -.
DR   MaxQB; P61081; -.
DR   PaxDb; P61081; -.
DR   PeptideAtlas; P61081; -.
DR   PRIDE; P61081; -.
DR   DNASU; 9040; -.
DR   Ensembl; ENST00000253023; ENSP00000253023; ENSG00000130725.
DR   GeneID; 9040; -.
DR   KEGG; hsa:9040; -.
DR   UCSC; uc002qtl.5; human.
DR   CTD; 9040; -.
DR   DisGeNET; 9040; -.
DR   GeneCards; UBE2M; -.
DR   HGNC; HGNC:12491; UBE2M.
DR   HPA; CAB004993; -.
DR   HPA; HPA054551; -.
DR   HPA; HPA057800; -.
DR   MIM; 603173; gene.
DR   neXtProt; NX_P61081; -.
DR   OpenTargets; ENSG00000130725; -.
DR   PharmGKB; PA37140; -.
DR   eggNOG; KOG0420; Eukaryota.
DR   eggNOG; ENOG410XS81; LUCA.
DR   GeneTree; ENSGT00630000089859; -.
DR   HOGENOM; HOG000233456; -.
DR   HOVERGEN; HBG098591; -.
DR   InParanoid; P61081; -.
DR   KO; K10579; -.
DR   OMA; HEPPKVR; -.
DR   OrthoDB; EOG091G0N8A; -.
DR   PhylomeDB; P61081; -.
DR   TreeFam; TF101125; -.
DR   Reactome; R-HSA-2173789; TGF-beta receptor signaling activates SMADs.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P61081; -.
DR   UniPathway; UPA00885; -.
DR   ChiTaRS; UBE2M; human.
DR   EvolutionaryTrace; P61081; -.
DR   GeneWiki; UBE2M; -.
DR   GenomeRNAi; 9040; -.
DR   PRO; PR:P61081; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130725; -.
DR   CleanEx; HS_UBE2M; -.
DR   ExpressionAtlas; P61081; baseline and differential.
DR   Genevisible; P61081; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019788; F:NEDD8 transferase activity; IDA:UniProtKB.
DR   GO; GO:0018169; F:ribosomal S6-glutamic acid ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IMP:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; IMP:UniProtKB.
DR   GO; GO:0038061; P:NIK/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0045116; P:protein neddylation; IDA:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Ligase;
KW   Methylation; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Ubl conjugation pathway.
FT   CHAIN         1    183       NEDD8-conjugating enzyme Ubc12.
FT                                /FTId=PRO_0000082488.
FT   REGION        1     57       Interaction with UBA3.
FT   ACT_SITE    111    111       Glycyl thioester intermediate.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:21940857,
FT                                ECO:0000269|PubMed:23201271}.
FT   MOD_RES       3      3       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     169    169       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:P61082}.
FT   MOD_RES     169    169       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MUTAGEN       1      1       M->A: No effect on thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN       4      4       L->A: Impairs thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN       5      5       F->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN       6      6       S->A: Slightly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN       7      7       L->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN       9      9       Q->A: Impairs thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN      10     10       Q->A: No effect on thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN      11     11       K->A: No effect on thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN      12     12       K->A: Impairs thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN      32     32       L->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      35     35       Q->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      36     36       K->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      38     38       I->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      39     39       N->A: No effect on thioester intermediate
FT                                formation. {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      41     41       L->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      51     51       F->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      55     55       D->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN      57     57       L->A: Strongly impairs thioester
FT                                intermediate formation.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     111    111       C->S: Forms a stable complex with NEDD8,
FT                                which prevents subsequent NEDD8
FT                                conjugation to cullins.
FT                                {ECO:0000269|PubMed:10828074}.
FT   HELIX         4     14       {ECO:0000244|PDB:3TDU}.
FT   HELIX        29     39       {ECO:0000244|PDB:1Y8X}.
FT   STRAND       47     50       {ECO:0000244|PDB:1Y8X}.
FT   STRAND       59     64       {ECO:0000244|PDB:1Y8X}.
FT   STRAND       67     69       {ECO:0000244|PDB:1Y8X}.
FT   TURN         70     73       {ECO:0000244|PDB:1Y8X}.
FT   STRAND       76     81       {ECO:0000244|PDB:1Y8X}.
FT   TURN         84     88       {ECO:0000244|PDB:1Y8X}.
FT   STRAND       92     95       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      108    110       {ECO:0000244|PDB:2NVU}.
FT   HELIX       113    115       {ECO:0000244|PDB:1Y8X}.
FT   TURN        116    118       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       125    137       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       147    154       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       157    169       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      170    173       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      176    178       {ECO:0000244|PDB:1Y8X}.
SQ   SEQUENCE   183 AA;  20900 MW;  E3C288CA6A98BC5C CRC64;
     MIKLFSLKQQ KKEEESAGGT KGSSKKASAA QLRIQKDINE LNLPKTCDIS FSDPDDLLNF
     KLVICPDEGF YKSGKFVFSF KVGQGYPHDP PKVKCETMVY HPNIDLEGNV CLNILREDWK
     PVLTINSIIY GLQYLFLEPN PEDPLNKEAA EVLQNNRRLF EQNVQRSMRG GYIGSTYFER
     CLK
//
